Suchergebnisse - "Patil, Vaishali M"

PubPharm (66)

41

Cinnamaldehyde Analogs : Docking Based Optimization, COX-2 Inhibitory In Vivo and In Vitro Studies

enthalten in: Current drug discovery technologies | 2020

von Patil, V. | Anand, P. | Bhardwaj, M. | +1

42

Quantum molecular modeling of hepatitis C virus inhibition through non-structural protein 5B polymerase receptor binding of C5-arylidene rhodanines

enthalten in: Computational biology and chemistry | 2018

von Balasubramanian, K. | Patil, V.

43

QSAR and Molecular Docking Directed Synthesis and Preliminary Evaluation of Novel Non-Nucleoside HCV NS5B Polymerase Inhibitors

enthalten in: Anti-infective agents | 2017

von Patil, V. | Masand, N. | R, G. | +4

44

Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer's Disease: An Overview

enthalten in: Central nervous system agents in medicinal chemistry | 2017

von Masand, N. | Gupta, S. | Khosa, R. | +1

45

QSAR and Molecular Docking Directed Synthesis and Preliminary Evaluation of Novel Non-Nucleoside HCV NS5B Polymerase Inhibitors

enthalten in: Anti-infective agents | 2017

von Patil, V. | Masand, N. | R, G. | +4

46

Quantum Chemical and Docking Insights into Bioavailability Enhancement of Curcumin by Piperine in Pepper

enthalten in: The journal of physical chemistry. A | 2016

von Patil, V. | Das, S. | Balasubramanian, K.

47

HCV Inhibitors : Role of Compounds from Botanical Sources

enthalten in: Current topics in medicinal chemistry | 2016

von Patil, V. | Masand, N. | Gupta, S.

48

GENIUS In Silico Screening Technology for HCV Drug Discovery

enthalten in: Current drug discovery technologies | 2016

von Patil, V. | Masand, N. | Gupta, S.

49

Studies on Chloride Channels and their Modulators

enthalten in: Current topics in medicinal chemistry | 2016

von Patil, V. | Gupta, S.

50

Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer's Disease : An Overview

enthalten in: Central nervous system agents in medicinal chemistry | 2015

von Masand, N. | Gupta, S. | Khosa, R. | +1